Cite

    Hideyuki Ikenaga et al.. “Phase III trial comparing the efficacy and safety of recombinant‐ or urine‐derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo‐ovulation and undergoing ovulation induction with follitropin‐alfa.” Reproductive medicine and biology, vol. 16, 2017, pp. 45–51. http://access.bl.uk/ark:/81055/vdc_100045415398.0x000037